R89L (p.Arg89Leu) variant of INS (Insulin)

R89L (p.Arg89Leu) in INS (Insulin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of INS-related disorders; Diabetes mellitus, permanent neonatal 4; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.72 / 1. The record also includes published literature and structural context.

R89L (p.Arg89Leu) variant details